Compare Abeona Therapeutics Inc (ABEO) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Redwire Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.43 (market cap $421.19M), while Redwire Corporation trades at $13.43 (market cap $3.38B). The key difference: Redwire Corporation is far larger — about 8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals.
| ABEO | RDW | |
|---|---|---|
Market Cap | $421.19M | $3.38B |
Sector | Health | Technology |
52-Week High | $7.45 | $25.90 |
52-Week Low | $4.17 | $5.06 |
Enterprise Value | $276.10M | $2.91B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
